Clarification on Standard Written Orders

Published in Government Relations on April 16, 2024

Ronda BuhrmesterRecently, the DME MACs released a Dear Physician Letter that clarified language on a standard written order (SWO) specifically related to CPAP masks. While the article was great news being welcomed by the industry, it also initiated additional conversation for other PAP supplies such as interfaces and tubing.

A SWO can have all the CPAP supplies listed separately (itemized). The descriptions of the items can be generic such as “CPAP mask”, this is applicable to either a full face mask or a nasal mask. The same SWO can have “tubing” listed to refer to either standard or heated tubing. The interfaces can also be a generic description.

The important pieces of information to be aware of when working with suppliers offering PAP supplies is making sure the SWO is not stating “CPAP supplies.” While the supplier can dispense with this type of order, the supplier cannot submit the claim for payment.  The SWO needs to be itemized. 

The other important piece of information is knowing that the interfaces would be listed separately because the quantities allowed each month are different. While both nasal replacement interfaces and full face replacement interfaces can be listed on the same SWO, the monthly allowed quantities are different. 

One last important piece of information is knowing the effective date of this change. The medical directors with the DME MACs have stated the guidance is for claims reviewed on or after February 1, 2024.

Even though this is a big win for our industry, we need to be mindful and not take advantage of the system. We can all agree the DME industry doesn’t need any more black eyes and we would not want this change reversed.

In summary, applicability is to all PAP supplies: The Dear Physician letter was intentionally written to address the issue of “mask swapping” only, an issue that industry stakeholders and the American Academy of Sleep Medicine asked the DME MACs to address in a recent “white paper.” PAP supplies, when separately billable, should be listed separately on the order. Two examples illustrate acceptable versus unacceptable orders for supplies:

  • Acceptable: “Tubing, Filter” – The DME MACs would allow this general description of the items, recognizing that the supplier’s knowledge of the base equipment dispensed, and patient medical need would dictate the type of tubing (e.g., standard vs heated) and filter (e.g., permanent vs disposable).
  • Unacceptable: “CPAP Supplies” – This would be considered inconsistent with CMS’ instructions to list separately billable items on the SWO.

Reach out to Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement for questions.


TAGS

  1. reimbursement
  2. respiratory

From Our Experts

Deadline To Comment On CMS' Proposed Rule Is Today thumbnail Deadline To Comment On CMS' Proposed Rule Is Today VGM Group has submitted our comments on the CY26 CMS DMEPOS/Home Health Proposed Rule and encourages you to do the same (if you haven't done so already)!  Our comments provide key recommendations aimed at protecting patient access and supporting the HME community.  VGM's Key Recommendations Include: CONNECT for Health Act Gains Bipartisan Telehealth Support thumbnail CONNECT for Health Act Gains Bipartisan Telehealth Support On April 2, 2025, a bipartisan group of 60 senators reintroduced the CONNECT for Health Act, legislation that would expand patient access to telehealth services through Medicare while removing barriers to adoption. The bill would also make permanent the COVID-19 telehealth flexibilities currently set to expire Sept. 30. The lead sponsors of the bill are Sens. Brian Schatz (D-HI), Roger Wicker (R-MS), Mark Warner (D-VA), Cindy Hyde-Smith (R-MS), Peter Welch (D-VT), and John Barrasso (R-WY). [Vlog] Important Updates Regarding NIPPV NCD thumbnail [Vlog] Important Updates Regarding NIPPV NCD Watch below an important update from Ronda Burhmester, Sr. Director Payer Relations & Reimbursement, VGM & Associates, regarding non-invasive pressure ventilation. Make Your Voice Heard On The Competitive Bidding Program thumbnail Make Your Voice Heard On The Competitive Bidding Program “If the Competitive Bidding Program goes forward, it will be devastating—not just for providers like me but, most importantly, for the patients we serve,” said Jonathan Temple, owner of OxyMed LLC. You Got the Contract! Part 2: Maintaining It thumbnail You Got the Contract! Part 2: Maintaining It In our last article, we discussed the key provisions to be sure you know about your contract. It is critical to understand these provisions to help comply with the contract terms, fulfill your obligations as your business changes, and understand the payer's obligations and your rights under the contract. In this article we discuss some best practices for managing your contracts once you get them. Industry Uncertainty & Advocacy: What You Can Do Now thumbnail Industry Uncertainty & Advocacy: What You Can Do Now The proposed rule introduces broad structural changes without full clarity on implementation timelines or enforcement. Industry groups like VGM, AAHomecare, and CQRC are urging stakeholders to engage in advocacy to shape final rules. To prepare for the sweeping changes in the 2025 CMS Proposed Rule for DMEPOS, companies should take a multi-pronged strategic approach. Here is a breakdown of key preparation strategies: Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director thumbnail Alabama Durable Medical Equipment Association (ADMEA) Seeks New Executive Director The Alabama Durable Medical Equipment Association (ADMEA) is now accepting applications for the role of Executive Director. This is an exciting leadership opportunity for an individual with a passion for healthcare, industry advocacy, and association management. 2025 CMS Proposed Rule Challenges and To-Dos thumbnail 2025 CMS Proposed Rule Challenges and To-Dos The 2025 CMS Proposed Rule for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) introduces several significant changes that present both operational and financial challenges for DME companies.